U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry EPIMERIC
Molecular Formula C25H36N2O8
Molecular Weight 492.5619
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OT-730

SMILES

CC1=CC(O)=C(O)C=C1C(=O)OC[C@H](CNC(C)(C)CNC(=O)C2CCOC2)OC(=O)C3(C)CC3

InChI

InChIKey=ANXXSWNMHQHOQC-DJNXLDHESA-N
InChI=1S/C25H36N2O8/c1-15-9-19(28)20(29)10-18(15)22(31)34-13-17(35-23(32)25(4)6-7-25)11-27-24(2,3)14-26-21(30)16-5-8-33-12-16/h9-10,16-17,27-29H,5-8,11-14H2,1-4H3,(H,26,30)/t16?,17-/m0/s1

HIDE SMILES / InChI
Othera Pharmaceuticals originally developed OT-730 (now known as QLT 091568) as an oculoselective beta-blocker for reducing the elevated intraocular pressure associated with glaucoma. OT-730 was involved in phase II clinical trial in patients with ocular hypertension or open-angle glaucoma. However, these studies were discontinued. At December 30, 2009, QLT Inc. acquired OT-730.

Approval Year

Sample Use Guides

one eye drop twice daily
Route of Administration: Other
Name Type Language
OT-730
Common Name English
OT 730
Code English
((2S)-3-((1,1-DIMETHYL-2-(TETRAHYDROFURAN-3-CARBONYLAMINO)ETHYL)AMINO)-2-(1-METHYLCYCLOPROPANECARBONYL)OXY-PROPYL) 4,5-DIHYDROXY-2-METHYL-BENZOATE
Systematic Name English
QLT-091568
Code English
BENZOIC ACID, 4,5-DIHYDROXY-2-METHYL-, (2S)-3-((1,1-DIMETHYL-2-(((TETRAHYDRO-3-FURANYL)CARBONYL)AMINO)ETHYL)AMINO)-2-(((1-METHYLCYCLOPROPYL)CARBONYL)OXY)PROPYL ESTER
Systematic Name English
Code System Code Type Description
FDA UNII
5WVS67PLAL
Created by admin on Sat Dec 16 11:32:08 GMT 2023 , Edited by admin on Sat Dec 16 11:32:08 GMT 2023
PRIMARY
CLINICAL_TRIALS.GOV
OT-730
Created by admin on Sat Dec 16 11:32:08 GMT 2023 , Edited by admin on Sat Dec 16 11:32:08 GMT 2023
PRIMARY The purpose of this study is to evaluate the safety and potential efficacy of a new drug, OT-730 ophthalmic solution (eye drops), in reducing intraocular pressure in the eyes of patients with open angle glaucoma or ocular hypertension. It will be compared with commercial timolol and placebo eye drops.
CAS
870809-51-1
Created by admin on Sat Dec 16 11:32:08 GMT 2023 , Edited by admin on Sat Dec 16 11:32:08 GMT 2023
PRIMARY
PUBCHEM
11554979
Created by admin on Sat Dec 16 11:32:08 GMT 2023 , Edited by admin on Sat Dec 16 11:32:08 GMT 2023
PRIMARY